Data as of 3:27pm ET
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Mabvax Therapeutics Holdings Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +757.14% increase from the last price of 7.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.